The in-ear region as a novel anatomical site for ECG signal detection: validation study on healthy volunteers.


Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 17 10 2019
accepted: 09 02 2020
pubmed: 18 2 2020
medline: 20 7 2021
entrez: 18 2 2020
Statut: ppublish

Résumé

Early detection of cardiac arrhythmias is a major opportunity for mobile health, as wearable devices nowadays available can detect single-lead electrocardiogram (ECG). The study aims to validate the in-ear region as a new anatomical site for ECG signal detection and looks towards designing innovative ECG wearable devices. We performed ECG using KardiaMobile device (AliveCor®) on 35 healthy volunteers. First, ECG was detected by standard modality using both hands. Then, ECG was detected using the left in-ear region instead of the right hand. All the recorded ECGs were analyzed by the device and by two cardiologists in blind testing. We successfully collected 70 ECGs performed on 35 volunteers (male 54%, age 39.1 ± 10.7 years; BMI 22.9 ± 2.89 kg/m The in-ear region is a reliable novel anatomical site for ECG signal detection in normal healthy subjects. Further studies are needed to validate this new ECG detection modality also in case of cardiac arrhythmias and to support the development of new wearable devices.

Identifiants

pubmed: 32064554
doi: 10.1007/s10840-020-00709-x
pii: 10.1007/s10840-020-00709-x
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-100

Références

Turakhia MP, Kaiser DW. Transforming the care of atrial fibrillation with mobile health. J Interv Card Electrophysiol. 2016;47:45–50.
doi: 10.1007/s10840-016-0136-3
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837–47.
doi: 10.1161/CIRCULATIONAHA.113.005119
Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142–7.
doi: 10.1016/j.amjcard.2013.05.063
Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746–51.
doi: 10.1093/eurheartj/eht280
Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213–20.
doi: 10.2147/CLEP.S47385
Steinberg JS, Varma N, Cygankiewicz I, Aziz P, Balsam P, Baranchuk A, et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Heart Rhythm. 2017;14(7):e55–96. https://doi.org/10.1016/j.hrthm.2017.03.038 .
doi: 10.1016/j.hrthm.2017.03.038 pubmed: 28495301
Kim MH, Johnston SS, Chu B-C, Dalal MR, Schulman KL. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Out- comes. 2011;4:313–20.
doi: 10.1161/CIRCOUTCOMES.110.958165
Panaccio MP, Cummins G, Wentworth C, Lanes S, Reynolds SL, Reynolds MW, et al. A common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical records. Clin Epidemiol. 2015;7:77–90.
doi: 10.2147/CLEP.S64936
Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, et al. Feasibility of extended ambulatory electrocardio- gram monitoring to identify silent atrial fibrillation in high-risk patients: the screening study for un- diagnosed atrial fibrillation (STUDY-AF). Clin Cardiol. 2015;38:285–92.
doi: 10.1002/clc.22387
Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, et al. Screening for atrial fibrillation: a report of the AF- SCREEN international collaboration. Circulation. 2017;135:1851–67.
doi: 10.1161/CIRCULATIONAHA.116.026693
Ip JE. Wearable devices for cardiac rhythm diagnosis and management. JAMA. 2019;321(4):337–8.
doi: 10.1001/jama.2018.20437
von Rosenberg W, Chanwimalueang T, Goverdovsky V, Peters NS, Papavassiliou C, Mandic DP. Hearables: feasibility of recording cardiac rhythms from head and in-ear locations. R Soc Open Sci. 2017;4(11):171214.
doi: 10.1098/rsos.171214
Zhang Q, Zhou D. Deep arm/ear-ECG image learning for highly wearable biometric human identification. Ann Biomed Eng. 2018;46:122–34.
doi: 10.1007/s10439-017-1944-z
Nantsupawat T, Nugent K, Phrommintikul A. Atrial fibrillation in the elderly. Drugs Aging. 2013;30(8):593–601.
doi: 10.1007/s40266-013-0094-8

Auteurs

R De Lucia (R)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy. r.delucia.md@gmail.com.

G Zucchelli (G)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

V Barletta (V)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

A Di Cori (A)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

M Giannotti Santoro (M)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

M Parollo (M)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

L Segreti (L)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

S Viani (S)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

V Della Tommasina (V)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

L Paperini (L)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

E Soldati (E)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

M G Bongiorni (MG)

Second Division of Cardiology, CardiacThoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56100, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH